4 results
Approved WMOCompleted
The aim of this study is to evaluate the effect of a single oral dose of TW001 on oxidative stress and pharmacokinetics with and without food. Dosing with an oral solution is considered to have major advantages over iv dosing in a chronic condition…
Approved WMOCompleted
The primary efficacy endpoint is treatment success in the therapy for mild to moderate Crohn*s disease with fisultas defined by: - A reduction of at least 50% in the number of draining fistulas at both week 4 and week 8
Approved WMOCompleted
To assess the effect of treatment with 100 mg of FAB122 (edaravone) on disease progression in patients with ALS.
Approved WMOCompleted
To evaluate the long-term safety of FAB122 in patients with ALS.